Sensorion SA (EPA:ALSEN)
France · Delayed Price · Currency is EUR 0.4180
-0.0070 (-1.65%)
Apr 2, 2026, 5:35 PM CET
Sensorion Market Cap
Sensorion has a market cap or net worth of €215.15 million as of April 2, 2026. Its market cap has increased by 54.98% in one year.
Market Cap
215.15M
Enterprise Value
168.93M
Revenue
5.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.42
Market Cap Chart
Since April 21, 2015, Sensorion's market cap has increased from 20.46M to 215.15M, an increase of 951.76%. That is a compound annual growth rate of 23.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 215.15M | 112.49% |
| Dec 31, 2025 | 101.25M | -47.00% |
| Dec 31, 2024 | 191.03M | 137.65% |
| Dec 29, 2023 | 80.38M | 171.97% |
| Dec 30, 2022 | 29.56M | -80.74% |
| Dec 31, 2021 | 153.45M | 33.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedinCell | 829.39M |
| Valneva SE | 470.87M |
| Genfit | 429.73M |
| Cellectis | 225.40M |
| Transgene | 202.63M |
| ABIONYX Pharma | 130.35M |
| Innate Pharma | 108.91M |
| MaaT Pharma | 107.63M |